Methylprednisolone-induced hepatotoxicity: Experiences from global adverse drug reaction surveillance

European Journal of Clinical Pharmacology

Volumn 70, Issue 4, 2014, Pages 501-503

  Caster, Ola ^a,b   Conforti, Anita ^c   Viola, Ermelinda ^c   Edwards, I Ralph ^a  

^a UPPSALA MONITORING CENTRE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

ADVERSE DRUG REACTION; DRUG MEGADOSE; DRUG SURVEILLANCE PROGRAM; LETTER; LIVER BIOPSY; LIVER FAILURE; LIVER FIBROSIS; LIVER TOXICITY; LOW DRUG DOSE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; TREATMENT DURATION; DRUG-INDUCED LIVER INJURY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMAN; MALE; MIDDLE AGED;

DRUG-INDUCED LIVER INJURY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED;

EID: 84896488465     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1632-3     Document Type: Letter

References (10)

1. Caster O, Norén GN, Madigan D, Bate A (2010) Large-Scale Regression-Based Pattern Discovery: The Example of Screening the WHO Global Drug Safety Database. Stat Anal Data Min 3:197-208
2. SOLU-MEDROL® US drug label http://www.accessdata.fda.gov/drugsatfda- docs/label/2011/011856s103s104lbl.pdf. Accessed 10 September 2013
3. Gutkowski K, Chwist A, Hartleb M (2011) Liver injury induced by high-dose methylprednisolone therapy: A case report and brief review of the literature. Hepat Mon 11:656-661
4. Youssef PP, Haynes DR, Triantafillou S, Parker A, Gamble JR, Roberts-Thomson PJ, Ahern MJ, Smith MD (1997) Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis Rheum 40:1400-1408 (Pubitemid 27430950)
5. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell ' Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A (2001) Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab 86: 3562-3567 (Pubitemid 32755944)
6. Compston A, Coles A (2000) Multiple sclerosis. Lancet 372:1502-1517
7. Sellebjerg F, Barnes D, Filippini G, Midgard R, Montalban X, Rieckmann P, Selmaj K, Visser LH, Sørensen PS (2005) EFNS guideline on treatment of multiple sclerosis relapses: Report of an EFNS task force on treatment of multiple sclerosis relapses. Eur J Neurol 12:939-946 (Pubitemid 41820048)
8. Miller DM, Weinstock-Guttman B, Bethoux F, Lee JC, Beck G, Block V, Durelli L, LaMantia L, Barnes D, Sellebjerg F, Rudick RA (2000) A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations. Mult Scler 6: 267-273
9. Fardet L, Kassar A, Cabane J, Flahault A (2007) Corticosteroid-induced adverse events in adults: Frequency, screening and prevention. Drug Saf 30:861-881 (Pubitemid 47481442)
10. Rivero Fernández M, Riesco JM, Moreira VF, Moreno A, López San Román A, Arranz G, Ruiz del Árbol L (2008) Recurrent acute liver toxicity of intravenous methylprednisolone. Rev Esp Enferm Dig 100:720-723